Genzyme Corporation v. Impax Laboratories, Inc.
1:09-cv-00653
Overview
Parties
Defendant
Endo Pharmaceuticals Inc. Operating Company
Represented By
2 Attorneys ListedSimms Showers LLP
201 International Circle, Suite 250
Office of Inspector General
U.S. Postal Service, 1735 North Lynn Street
Plaintiff
Court & Judges
Court
District Court, D. Maryland (mdd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 14 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 6,733,780 B1 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2002005490 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2005026023 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2004016615 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2006003491 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2008029269 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,187,631 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2012032171 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2012032289 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2013031599 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,579,343 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,931,358 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 16,025,899 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 17,422,700 P | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6733780
Direct compression polymer tablet core
|
Filed: 2000-10-18
Issued: 2004-05-11
|
Expired (Term Ended)
Expires: 2020-10-18
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
59
Dispositive
7
Granted
16
Denied
0
Pending / Review
22
Motions by Category
Key Dispositive Motions & Rulings